Renal Tuberculosis Following Intravesical Bacillus Calmette-Guérin for High-grade Non-muscle-invasive Bladder Cancer

Urology. 2017 Sep:107:e3-e4. doi: 10.1016/j.urology.2017.05.035. Epub 2017 May 31.

Abstract

A 47-year-old man presented to the urology department with visible hematuria. He was found to have a high-grade non-muscle-invasive transitional cell carcinoma of the bladder and was subsequently treated with intravesical Bacillus Calmette-Guérin instillations. On routine surveillance computed tomography scan following treatment, he was found to have multiple rounded areas of low density in the right kidney, suspicious for renal malignancy. He underwent renal biopsy that revealed necrotizing granulomatous inflammation suggestive of mycobacterial infection. He was successfully treated with antituberculosis therapy.

Publication types

  • Case Reports

MeSH terms

  • Administration, Intravesical
  • BCG Vaccine / administration & dosage
  • BCG Vaccine / adverse effects*
  • Biopsy
  • Carcinoma, Transitional Cell / diagnosis
  • Carcinoma, Transitional Cell / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging*
  • Tomography, X-Ray Computed
  • Tuberculosis, Renal / chemically induced*
  • Tuberculosis, Renal / diagnosis
  • Urinary Bladder Neoplasms / diagnosis
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • BCG Vaccine